NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / Technology News / COVID-19 nasal vaccines are available but should you get one? 
    Next Article
    COVID-19 nasal vaccines are available but should you get one? 
    Bharat Biotech's nasal vaccine has been approved for use in India (Photo credit: Dzmitry Kliapitski)

    COVID-19 nasal vaccines are available but should you get one? 

    By Sanjana Shankar
    Dec 23, 2022
    07:13 pm

    What's the story

    The Centre has given its nod to Bharat Biotech's nasal vaccine: iNCOVACC. It has been included in the COVID-19 vaccination program and has been approved to be used as a heterologous booster from today.

    But the burning concerns are whether nasal vaccines are efficacious and whether they can help curb the transmission of the COVID-19 virus.

    Let's take a look.

    Context

    Why does this story matter?

    iNCOVACC is the first nasal vaccine in India to be approved by the government. There are more than 100 mucosal vaccines that are being developed across the world.

    The needle-free vaccines might also help overcome the reluctance among certain parts of the population who refrain from getting jabs.

    Given the promising results of nasal vaccines, they could be a game-changer.

    Explanation

    First, what are nasal vaccines?

    Nasal vaccines, as the name suggests, are administered via the nose as opposed to the most commonly used intramuscular route.

    These vaccines offer several advantages compared to traditional vaccination approaches such as convenience, ease of delivery, cost, and disposal.

    Furthermore, several studies report that intranasal administration of COVID-19 vaccines can prevent disease development as well as limit the transmission of the virus.

    Mechanism

    How do nasal vaccines work?

    Nasal vaccines target mucous membranes lining the nose, mouth, and lungs.

    The mechanism by which they work is that nasal vaccines act as the "first entry block" and produce immune responses where the pathogen first enters the body. This subsequently prevents the infection and curbs the spread to other people, something which the current intramuscular vaccines cannot do.

    Description

    Tissue-resident memory cells produce immunoglobulin A antibodies

    The immune cells in the mucosal linings are referred to as tissue-resident memory T and B cells and they function differently from the T cells and B cells that are in circulation.

    The tissue-resident memory B cells produce antibodies called secretory immunoglobulin A (or IgA), which are also predominantly present in external secretions, including mucus in the digestive tract, saliva, and tears.

    Process

    The IgA antibodies can entrap and block pathogens

    IgA has various functions in mucosal defense, including entrapping pathogens and preventing them from direct contact with the mucosal surface and thereby blocking them.

    However, a more pressing concern is the evolving variants of the COVID-19 virus, which have the potential to evade or suppress the immune system, and a changed route of administration does not address this issue.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    COVID-19
    COVID-19 Vaccine
    Bharat Biotech

    Latest

    Supreme Court acquits man sentenced to death for 3-year-old's rape-murder  Bombay High Court
    Chivanga replaces injured Gwandu in Zimbabwe's one-off Test versus England Zimbabwe Cricket Team
    Decoding scenario of overseas players for remainder of IPL 2025 Gujarat Titans
    Chris Brown's UK assault case moved to higher court Chris Brown

    COVID-19

    Lakshmi-Ganesh pics on currency will revive economy: Kejriwal to Modi Arvind Kejriwal
    China: 'Jimmy Jimmy Aaja Aaja' becomes COVID-19 protest song China
    Meet new CJI Chandrachud, who bats for progressive, liberal values DY Chandrachud
    800 test COVID-19 positive on Australian cruise ship in Sydney Australia

    COVID-19 Vaccine

    COVID-19 vaccine booster: Are they really required? Expert answers World Health Organization
    ZyCoV-D expected to be rolled out in two weeks: Report Zydus Cadila
    Coronavirus: 70% of India's adult population receive 1 vaccine dose Union Health Ministry
    WHO expert panel to discuss COVAXIN approval in meet today World Health Organization

    Bharat Biotech

    Nepal gives emergency use approval to Bharat Biotech's COVAXIN Nepal
    COVAXIN manufacturing facility fails to meet CGMP standards: Brazilian regulator Brazil
    Bharat Biotech to produce 700 million COVAXIN doses per year COVID-19
    Bharat Biotech reduces COVAXIN price to Rs. 400 for states Vaccine
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025